Herbalife Ltd


  • Greenberg on Herbalife     Tuesday, 1 May 2012 | 2:00 PM ET

    Shares of Herbalife are dropping since David Einhorn questioned the company's disclosures during a conference call, with CNBC's Herb Greenberg.

  • CNBC's Herb Greenberg reports on shares of Herbalife falling 20% after influential investor David Einhorn asked the company serious questions during a conference call.

  • Trading Chesapeake Energy Now     Tuesday, 1 May 2012 | 12:30 PM ET

    Chesapeake Energy announced it will terminate its FWPP and will separate CEO and chairman positions. Jon Najarian, OptionMonster.com and Fadel Gheit, Oppenheimer analyst, discuss the positive developments for the company.

  • Herbalife Shares Falter     Tuesday, 1 May 2012 | 12:00 PM ET

    The FMHR traders discuss the current state of the economy and the trade on Herbalife since David Einhorn questioned the company's disclosure. Stephen Weiss, Short Hills Capital; and CNBC's Bertha Coombs and Herb Greenberg weigh in.

  • Herbalife Shares Halted     Tuesday, 1 May 2012 | 11:52 AM ET

    CNBC's Bertha Coombs reports that Herbalife shares have halted.

  • After Hours Movers: Monster Beverages     Monday, 30 Apr 2012 | 4:24 PM ET

    CNBC's Seema Mody reports on which stocks are making big moves after hours, including Monster Beverage and Anadarko Petroleum.

  • 10 Small-Cap Stocks Safe for Skittish Investors Friday, 23 Mar 2012 | 1:32 PM ET
    Traders work in the ten-year U.S. Treasury Note options pit at the Chicago Board of Trade in Chicago, Illinois, U.S.

    Here are 10 of the top stock picks of three low-volatility, highly rated small-cap growth funds, ranked in inverse order of their number of “buy” ratings.

  • Herbalife Responds to Herb     Wednesday, 14 Mar 2012 | 2:41 PM ET

    CNBC's Herb Greenberg knocked Herbalife last week for claiming it does a substantial amount of R&D, but not disclosing the amount it spends. Now, Herbalife offers a response.

  • Herbalife Expands R&D Disclosure: Greenberg Wednesday, 14 Mar 2012 | 1:43 PM ET

    Last week, I knocked Herbalife for claiming it does a bunch of R&D, but not disclosing the amount it spends on it. Then, later in the week, without fanfare, the nutritional supplement company updated the R&D section of its website to show the amount they spend on R&D and other stuff.

  • Top Three Trades, Buy JPM     Friday, 9 Mar 2012 | 12:41 PM ET

    The Fast Money traders reveal their top three trades, with Josh Brown, of Fusion Analytics, who explains why JPMorgan is one of the best positioned banks in the nation, and Romit Shah, of Nomura, explains why Texas Instruments cut its forecast.

  • Herbalife: Believe the Hype?     Tuesday, 6 Mar 2012 | 2:21 PM ET

    CNBC's Herb Greenberg raises the red flag on Heralife because he thinks they overhype their research. Timothy Ramey, D.A. Davidson, weighs in.

  • Questioning Herbalife’s 'Research': Greenberg Tuesday, 6 Mar 2012 | 12:40 PM ET

    When a company brags about the amount of research it does, you would expect to “research and development” broken out as an expense somewhere in its SEC filings. At most companies, maybe, but not at Herbalife.

  • Herbalife: Cutting Edge or Old Remedies?     Tuesday, 6 Mar 2012 | 12:39 PM ET

    CNBC's Herb Greenberg takes a look at why Herbalife stock has managed to triple in price. Also, what happens when a CEO says one thing and files something completely different with the SEC.

  • Making Money Without the Speculation Rush Friday, 24 Feb 2012 | 5:32 PM ET

    Speculation has its place, but Cramer's researcher thinks there is lots of opportunity to profit from established companies, too.

  • Herbalife Shares Gain on Obesity Play     Wednesday, 22 Feb 2012 | 6:25 PM ET

    Michael Johnson, Herbalife CEO, discusses his company's big earnings beat and 50% dividend boost, with Mad Money's Jim Cramer.

  • Jeremy Lin vs Charles Barkley: Linning vs Losing Thursday, 16 Feb 2012 | 6:00 PM ET

    Jim Cramer’s researcher, Nicole Urken, takes a look at why there is limited near-term upside for Weight Watchers stock … with a nod toward linsanity

  • Your First Move For Monday February 13th Friday, 10 Feb 2012 | 6:25 PM ET

    Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!

  • Cramer makes the call on viewers' favorite stocks.

  • Buy Banks Ahead of RBA Meeting Next Week     Sunday, 29 Jan 2012 | 10:40 PM ET

    Simon Burge, Chief Investment Officer, ATI Asset Management likes financials right now, especially ANZ, NAB and Westpac on the back of good yields.

  • Lightning Round: Macy's, Travelzoo, Dole Food and More Tuesday, 10 Jan 2012 | 8:11 PM ET

    Cramer makes the call on viewers' favorite stocks.